Distribution of Intestinal Parasites in Patients Admitted to University Hospital: Four Year Retrospective Review.

Objective: In this study, it was aimed to examine the distribution of intestinal parasites detected in people who applied to the parasitology laboratory of Firat University Faculty of Medicine between January 2018 and December 2021. Methods: Parasitological examination reports of a total of 24,432 patients who applied to the Parasitology Laboratory of Firat University Faculty of Medicine between January 2018 and December 2021 were examined retrospectively for the presence of intestinal parasites. Results: A total of 24,432 (male: 12,887, 52.75%; female: 11,545, 47.25%) patients whose stool and cellophane tape samples were analyzed during the four-year period between January 2018 and December 2021 were included in the study. Intestinal parasites were found in 335 (1.4%) of the 24,432 patients examined. The most frequently detected parasite was Giardia intestinalis (n=149, 46.6%), followed by Entamoeba coli (n=123, 38.5%) and Enterobius vermicularis (n=28, 8.6%). When the distribution of parasite detection rates by years was examined, it was seen that the highest rate was in 2021 and the lowest rate was in 2019. Conclusion: Intestinal parasitic infections (IPE) are one of the most important public health problems in the world and in our country. Various factors such as the education level of the society, socio-economic status, infrastructure and climate affect the distribution of IPE. When we look at the distribution of parasites by years, it is 1.3% in 2018; 1.13% in 2019; 1.18% in 2020; In 2021, we found it to be 2.03%. We think that this increase in intestinal parasites is caused by the infrastructure and sheltering problems caused by the earthquake in our region.

Factors affecting onychomycosis in patients with psoriasis.

Prevalence of onychomycosis increases in patients with psoriasis and that psoriasis predisposes to onychomycosis. It was aimed to determine the frequency of onychomycosis and responsible pathogens in patients with psoriasis, to reveal their differences compared to the population without psoriasis, and to determine the factors in this study. The study included 81 patients with nail disorder diagnosed with psoriasis. Clinical findings, psoriasis area and severity index (PASI), nail psoriasis severity index (NAPSI) scores, body mass indexes (BMI) and laboratory characteristics were recorded. Mycological examination by direct microscopy and fungal culture was performed both on nails that were considered onychomycosis and on nails with any of the psoriatic nail findings. The prevalence of onychomycosis was 27.2% in psoriasis patients. Nail involvement of psoriasis was found in 31.3% of the patients using biologic agents, 5.9% of those receiving conventional treatment, and 31.3% of those receiving topical treatment and 68.8% of the patients who did not receive treatment at all. The difference between the patients who did not receive treatment and those who received conventional treatment was significant (p < 0.05). There was growth in the fungal culture in 23.5% of the patients with psoriasis. There was no statistically significant relationship between onychomycosis and PASI, NAPSI score, and BMI (p > 0.05). Since the prevalence of onychomycosis in psoriasis patients receiving conventional and anti-TNF-α therapy is higher than in patients not receiving treatment, nail changes in these patients should be evaluated in more detail for the presence of onychomycosis. In addition, since more than one fungal agent can grow and non-dermatophyte molds are seen more frequently in patients with psoriasis, it should be taken into account that native and fungal culture examinations should be performed together.